Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:21:42.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A banner announces an NIH transition from the term “artificial intelligence” to “super intelligence” and directs visitors to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-24T12:49:54.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T14:38:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T14:40:57.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new revision label v3.7.0 is added to the page history, while the previous v3.6.6 entry is removed. This reflects an update to the record's versioning.
    Difference
    0.1%
    Check dated 2026-09-19T22:01:01.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now listed as the latest version in the record history, replacing the previous v3.6.5; this indicates a site software update rather than a change to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-08-29T21:58:18.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.